SHANGHAI and CAMBRIDGE, Mass, Nov. 14, 2026 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, today announced that five of its commercial medicines in China have been included in the country's 2026 National Reimbursement Drug List (NRDL). The update includes two first-time listings,...
TAIPEI, Jan. 16, 2026 /PRNewswire/ -- As artificial intelligence continues to move from experimentation toward real-world adoption, GIGABYTE presents a clear local AI solution...
Infobip announces key leadership changes with promotions of internal executives, effective 1 January 2026 KUALA LUMPUR, Malaysia, Jan. 16, 2026 /PRNewswire/ -- Global...
GUANGZHOU, China, Jan. 15, 2026 /PRNewswire/ -- On January 14, 2026, Guangzhou Zhongshan Whampoa School for Hong Kong and Macao Students (ZWIS) and Foshan Zhongshan...